Inhalable liposomes of low molecular wei
โ
Shuhua Bai; Fakhrul Ahsan
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 456 KB
This study tests the feasibility of inhalable pegylated liposomal formulations of low molecular weight heparin (LMWH) for treatment of two clinical manifestations of vascular thromboembolism: deep vein thrombosis (DVT) and pulmonary embolism (PE). Conventional distearoyl-sn-glycero-3-phosphoethanola